Thursday, November 12, 2009

Rheumatoid Arthritis Home>
Rheumatoid Arthritis News>
New drug Masitinib shows promise against RA

Font size
- A
- A
- A
Email This

Bookmark

Save

Receive a FREE Osteoarthritis of the knee pamphlet. Start here.

New drug Masitinib shows promise against RA

(U.S. News and World Report) UPDATED 2009-06-26

A new drug being developed to treat rheumatoid arthritis (RA) has show good results in a new small study. The drug, called Masitinib, is designed to stop the activity of mast cells, which are a part of the immune system believed to be involved in both the start and progression of RA. In a new study of 43 people, researchers found that the drug was effective at reducing joint inflammation in people with severe RA while causing only mild to moderate side effects. Scientists say the next step for the drug is placebo-controlled studies. Read full story >

See all Rheumatoid Arthritis News

Related: Masitinib

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyRACentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.